96 related articles for article (PubMed ID: 15373563)
21. Characterization of a macaque anti-Rh17-like monoclonal antibody.
Blancher A; Roubinet F; Reid ME; Socha WW; Bailly P; Bénard P
Vox Sang; 1998; 75(1):58-62. PubMed ID: 9745155
[TBL] [Abstract][Full Text] [Related]
22. Case report: IgG1 Rh antibodies causing moderate hemolytic disease of the newborn.
Kugele E; Carney M; Oliver C; Hollander J
Immunohematology; 1994; 10(4):124-6. PubMed ID: 15945813
[TBL] [Abstract][Full Text] [Related]
23. [Hemolytic disease of neonates due to anti-M: report of one case and review of reports of 21 cases].
Gao XY; Huang H; Li LD
Zhonghua Er Ke Za Zhi; 2009 Sep; 47(9):648-52. PubMed ID: 20021783
[TBL] [Abstract][Full Text] [Related]
24. Hemolytic disease of the newborn due to anti-jkb: case report and review of the literature.
Velasco Rodríguez D; Pérez-Segura G; Jiménez-Ubieto A; Rodríguez MA; Montejano L
Indian J Hematol Blood Transfus; 2014 Jun; 30(2):135-8. PubMed ID: 24839369
[TBL] [Abstract][Full Text] [Related]
25. Use of a PCR-based assay for fetal Cw antigen genotyping in a patient with a history of moderately severe hemolytic disease of the newborn due to anti-Cw.
Reiner AP; Teramura G; Aramaki KM
Am J Perinatol; 1999; 16(6):277-81. PubMed ID: 10586980
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the enzyme test for the detection of clinically significant red blood cell antibodies during pregnancy.
Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
Acta Med Croatica; 1999; 53(3):125-8. PubMed ID: 10705633
[TBL] [Abstract][Full Text] [Related]
27. Rh-incompatible hemolytic disease of the newborn in Hefei.
Bi SH; Jiang LL; Dai LY; Zheng H; Zhang J; Wang LL; Wang C; Jiang Q; Liu Y; Zhang YL; Wang J; Zhu C; Liu GH; Teng RJ
World J Clin Cases; 2019 Oct; 7(20):3202-3207. PubMed ID: 31667170
[TBL] [Abstract][Full Text] [Related]
28. [A case of severe hemolytic disease of the newborn due to anti-Dia antibody].
Lee SM; Im SJ; Park SE; Lee EY; Kim HH
Korean J Lab Med; 2007 Oct; 27(5):373-6. PubMed ID: 18094604
[TBL] [Abstract][Full Text] [Related]
29. Do monocyte ADCC assays accurately predict the severity of hemolytic disease of the newborn caused by antibodies to high-frequency antigens?
Garner SF; Devenish A
Immunohematology; 1996; 12(1):20-6. PubMed ID: 15387757
[TBL] [Abstract][Full Text] [Related]
30. Severe hemolytic disease of the newborn from anti-e.
McAdams RM; Dotzler SA; Winter LW; Kerecman JD
J Perinatol; 2008 Mar; 28(3):230-2. PubMed ID: 18309317
[TBL] [Abstract][Full Text] [Related]
31. Intravenous Immunoglobulin therapy for anti-E hemolytic disease in the newborn.
Onesimo R; Rizzo D; Ruggiero A; Valentini P
J Matern Fetal Neonatal Med; 2010 Sep; 23(9):1059-61. PubMed ID: 20092394
[TBL] [Abstract][Full Text] [Related]
32. Anti-Jk3 with no clinical evidence of HDN.
Hunter CJ; Ziebol MD
Immunohematology; 1997; 13(4):136-7. PubMed ID: 15387767
[TBL] [Abstract][Full Text] [Related]
33. Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN).
Payam Khaja Pasha R; Shokri F
Iran J Immunol; 2008 Dec; 5(4):189-200. PubMed ID: 19098362
[TBL] [Abstract][Full Text] [Related]
34. Non-invasive fetal RHD and RHCE genotyping from maternal plasma in alloimmunized pregnancies.
Hromadnikova I; Vesela K; Benesova B; Nekovarova K; Duskova D; Vlk R; Spalova I; Gerychova R; Hakenova A; Rosenbaumova Z; Vlasin P; Vlachova A; Palasek V; Roznakova E; Calda P
Prenat Diagn; 2005 Dec; 25(12):1079-83. PubMed ID: 16231295
[TBL] [Abstract][Full Text] [Related]
35. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].
Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952
[TBL] [Abstract][Full Text] [Related]
36. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation.
Chan FY; Cowley NM; Wolter L; Stone M; Carmody F; Saul A; Hyland CA
Prenat Diagn; 2001 Apr; 21(4):321-6. PubMed ID: 11288127
[TBL] [Abstract][Full Text] [Related]
37. Warm autoimmune hemolytic anemia with mimicking anti-c and -E specificities.
Hsieh HY; Moroney D; Naumann D; Hata J; Vosnidou N; Kessinger R; Shahab N; Hakami N; Smith D
Immunohematology; 2002; 18(1):19-22. PubMed ID: 15373571
[TBL] [Abstract][Full Text] [Related]
38. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
[TBL] [Abstract][Full Text] [Related]
39. IgG red blood cell autoantibodies in autoimmune hemolytic anemia bind to epitopes on red blood cell membrane band 3 glycoprotein.
Victoria EJ; Pierce SW; Branks MJ; Masouredis SP
J Lab Clin Med; 1990 Jan; 115(1):74-88. PubMed ID: 1688911
[TBL] [Abstract][Full Text] [Related]
40. Management of pregnancy complicated by anti-hrB/anti-HrB.
Win N; Needs M; Tillyer L
Immunohematology; 2007; 23(4):143-5. PubMed ID: 18284303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
